Yayın: Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group
| dc.contributor.author | Turhal, N. S. | |
| dc.contributor.author | Üskent, Necdet | |
| dc.contributor.author | Erman Akkuş | |
| dc.contributor.author | Elif Berna Köksoy | |
| dc.contributor.author | Naziyet Köse | |
| dc.contributor.author | Bala Başak Öven | |
| dc.contributor.author | Başak Oyan Uluç | |
| dc.contributor.author | Atike Gökçen Demiray | |
| dc.contributor.author | Di̇lek Erdem | |
| dc.contributor.author | Bilgin Demir | |
| dc.contributor.author | N. S. Turhal | |
| dc.contributor.author | Necdet Üskent | |
| dc.contributor.author | Sinem Akbaş | |
| dc.contributor.author | Fatih Selçukbırıcık | |
| dc.contributor.author | Ali İnal | |
| dc.contributor.author | Ahmet Bılıcı | |
| dc.contributor.author | Ömer Fatih Ölmez | |
| dc.contributor.author | Devrim Çabuk | |
| dc.contributor.author | Çağlar Ünal | |
| dc.contributor.author | Mutlu Hızal | |
| dc.contributor.author | Mehmet Alı Nahıt Şendur | |
| dc.contributor.author | Mustafa Korkmaz | |
| dc.contributor.author | Nuri Karadurmuş | |
| dc.contributor.author | İsmail Ertürk | |
| dc.contributor.author | Sema Sezgin Göksu | |
| dc.contributor.author | Ali Murat Tatlı | |
| dc.contributor.author | Deniz Can Güven | |
| dc.contributor.author | Saadettin Kılıçkap | |
| dc.contributor.author | Nail Paksoy | |
| dc.contributor.author | Adnan Aydıner | |
| dc.contributor.author | Havva Yeşil Çınkır | |
| dc.contributor.author | Özlem Özkul | |
| dc.contributor.author | Akın Öztürk | |
| dc.contributor.author | Sevinç Ballı | |
| dc.contributor.author | Yasemi̇n Kemal | |
| dc.contributor.author | Atike Pınar Erdoğan | |
| dc.contributor.author | Özlem Er | |
| dc.contributor.author | Perran Fulden Yumuk | |
| dc.contributor.author | Ahmet Demirkazık | |
| dc.contributor.orcid | 0000-0001-7680-4142 | |
| dc.contributor.orcid | 0000-0003-2184-634X | |
| dc.contributor.orcid | 0000-0002-7531-7817 | |
| dc.contributor.orcid | 0000-0002-6590-4444 | |
| dc.contributor.orcid | 0000-0002-6623-6273 | |
| dc.contributor.orcid | 0000-0003-4397-5468 | |
| dc.contributor.orcid | 0000-0001-6495-6712 | |
| dc.contributor.orcid | 0000-0003-4380-9419 | |
| dc.contributor.orcid | 0000-0002-1013-5676 | |
| dc.contributor.orcid | 0000-0003-2739-7362 | |
| dc.contributor.orcid | 0000-0002-1273-1674 | |
| dc.contributor.orcid | 0000-0001-9510-9858 | |
| dc.contributor.orcid | 0000-0002-0443-6966 | |
| dc.contributor.orcid | 0000-0001-7934-7039 | |
| dc.contributor.orcid | 0000-0002-7871-6311 | |
| dc.contributor.orcid | 0000-0003-3245-1570 | |
| dc.contributor.orcid | 0000-0001-5147-4431 | |
| dc.contributor.orcid | 0000-0001-7021-6139 | |
| dc.contributor.orcid | 0000-0003-0926-6748 | |
| dc.contributor.orcid | 0000-0003-3291-8062 | |
| dc.contributor.orcid | 0000-0003-3204-4430 | |
| dc.contributor.orcid | 0000-0002-8026-764X | |
| dc.contributor.orcid | 0000-0001-9696-1102 | |
| dc.contributor.orcid | 0000-0002-6924-9467 | |
| dc.contributor.orcid | 0000-0003-1637-7390 | |
| dc.contributor.orcid | 0000-0003-4636-2595 | |
| dc.contributor.orcid | 0000-0002-1104-5840 | |
| dc.contributor.orcid | 0000-0002-7870-8741 | |
| dc.contributor.orcid | 0000-0003-4413-0133 | |
| dc.contributor.orcid | 0000-0002-3445-3804 | |
| dc.contributor.orcid | 0000-0002-1175-9085 | |
| dc.contributor.orcid | 0000-0003-4859-7574 | |
| dc.contributor.orcid | 0000-0002-9272-2400 | |
| dc.contributor.orcid | 0000-0001-8650-299X | |
| dc.contributor.orcid | 0000-0002-2917-7999 | |
| dc.date.accessioned | 2025-11-13T10:21:22Z | |
| dc.date.issued | 2022-06-11 | |
| dc.identifier.doi | https://doi.org/10.1007/s00432-022-04087-x | |
| dc.identifier.endpage | 3555 | |
| dc.identifier.issn | 0171-5216 | |
| dc.identifier.issue | 12 | |
| dc.identifier.openalex | W4282927265 | |
| dc.identifier.startpage | 3547 | |
| dc.identifier.uri | https://hdl.handle.net/11421/3898 | |
| dc.identifier.uri | https://doi.org/10.1007/s00432-022-04087-x | |
| dc.identifier.volume | 148 | |
| dc.language.iso | en | |
| dc.relation.ispartof | Journal of Cancer Research and Clinical Oncology | |
| dc.rights | openAccess | |
| dc.subject | Atezolizumab | |
| dc.subject | Medicine | |
| dc.subject | Internal medicine | |
| dc.subject | Oncology | |
| dc.subject | Lung cancer | |
| dc.subject | Chemotherapy | |
| dc.subject | Univariate analysis | |
| dc.subject | Stage (stratigraphy) | |
| dc.subject | Cancer | |
| dc.subject | Multivariate analysis | |
| dc.subject | Immunotherapy | |
| dc.subject | Pembrolizumab | |
| dc.subject.sdg | 3 | |
| dc.title | Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.authorid.openalex | A5064011743 | |
| local.authorid.openalex | A5064757657 |
